Clinical Outcomes and Prognostic Factors in Locally Advanced Breast Cancer Patients with Estrogen Receptor-Positive, HER2-Negative Subtype Treated with Neoadjuvant Chemotherapy and Surgery Followed by Postmastectomy Radiation Therapy

Tokumasu K.; Nakajima N.; Yoshioka Y.; Oguchi M.

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Clinical Outcomes and Prognostic Factors in Locally Advanced Breast Cancer Patients with Estrogen Receptor-Positive, HER2-Negative Subtype Treated with Neoadjuvant Chemotherapy and Surgery Followed by Postmastectomy Radiation Therapy

【24h】

Clinical Outcomes and Prognostic Factors in Locally Advanced Breast Cancer Patients with Estrogen Receptor-Positive, HER2-Negative Subtype Treated with Neoadjuvant Chemotherapy and Surgery Followed by Postmastectomy Radiation Therapy

机译：雌激素受体阳性雌激素受体阳性患者患者临床结果和预后因素，用新辅助化疗和手术治疗，后术后辐射治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics》 |2019年第1suppla期|共2页
作者
Tokumasu K.; Nakajima N.; Yoshioka Y.; Oguchi M.;
展开▼
作者单位

JFCR Canc Inst Hosp Dept Radiat Oncol Tokyo Japan;

JFCR Canc Inst Hosp Dept Radiat Oncol Tokyo Japan;

JFCR Canc Inst Hosp Dept Radiat Oncol Tokyo Japan;

JFCR Canc Inst Hosp Dept Radiat Oncol Tokyo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical Outcomes and Prognostic Factors in Locally Advanced Breast Cancer Patients with Estrogen Receptor-Positive, HER2-Negative Subtype Treated with Neoadjuvant Chemotherapy and Surgery Followed by Postmastectomy Radiation Therapy [J] . Tokumasu K., Nakajima N., Yoshioka Y., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：雌激素受体阳性雌激素受体阳性患者患者临床结果和预后因素，用新辅助化疗和手术治疗，后术后辐射治疗
2. Correspondence on the article: "Patients treated with neoadjuvant chemotherapy plus radical surgery plus adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up" [J] . Ali Nasir, Abbasi Ahmed Nadeem, Mansha Muhammad Atif Medical oncology . 2016,第11期

机译：关于文章的对应：“患有Neoadjuvant化疗治疗的患者加上自由基手术加上局部晚期宫颈癌的佐剂化疗：长期成果，在单中心10年随访中的长期结果，存活和预后因素”
3. Patients treated with neoadjuvant chemotherapy plus radical surgery plus adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up [J] . Luvero Daniela, Plotti Francesco, Aloisi Alessia, Medical oncology . 2016,第10期

机译：患有Neoadjuvant化疗治疗加根治医疗宫颈癌的辅助化疗：单中心10年随访中的长期成果，生存和预后因素
4. Impact of Prognostic Factors for Postmastectomy Radiation Therapy of Breast Cancer Patients [C] . K. A. Simonov, Zh. A. Startseva, E. M. Slonimskaya, International Conference on Physics of Cancer : Interdisciplinary Problems and Clinical Applications . 2017

机译：预后因素对乳腺癌患者后切除辐射治疗的影响
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era [O] . Naomi Nakajima, Masahiko Oguchi, Yasuko Kumai, 2018

机译：在现代治疗时代新辅助化学疗法治疗并经手术和乳房切除术后放疗的II-III期乳腺癌患者的临床结局和预后因素
7. Clinical Outcomes and Prognostic Factors in Locally Advanced Breast Cancer Patients with Estrogen Receptor-Positive, HER2-Negative Subtype Treated with Neoadjuvant Chemotherapy and Surgery Followed by Postmastectomy Radiation Therapy [O] . K. Tokumasu, N. Nakajima, Y. Yoshioka, 2019

机译：雌激素受体阳性雌激素受体阳性患者患者临床结果和预后因素，用新辅助化疗和手术治疗，后术后辐射治疗

Clinical Outcomes and Prognostic Factors in Locally Advanced Breast Cancer Patients with Estrogen Receptor-Positive, HER2-Negative Subtype Treated with Neoadjuvant Chemotherapy and Surgery Followed by Postmastectomy Radiation Therapy

著录项

引文网络

相似文献

相关主题

期刊订阅